L. Jay Katz, MD, is Director of the Glaucoma Service at Wills Eye Hospital in Philadelphia, and is a Professor of Ophthalmology at Jefferson Medical College. He obtained his medical degree at Yale University School of Medicine, his residency in ophthalmology at Yale-New Haven Hospital and his fellowship in glaucoma at Wills Eye Hospital. His current research interests in glaucoma include drug evaluation, glaucoma surgery devices and techniques, scanning technologies for the optic nerve and instrumentation for measurement of intra-ocular pressure.
Alan M. Laties, MD, completed residency training in Ophthalmology and became a Special Fellow of the NIH at the Institute of Neurological Sciences of the University of Pennsylvania Medical School. He then joined the faculty of the Medical School with a joint appointment in Ophthalmology and Neurology. Thereafter he served as Neuro-ophthalmologist at the Hospital of the University of Pennsylvania while pursuing research interests that mainly concerned autonomic innervation, eye growth and therapeutic approaches to retinal degenerations. He has served as Editor-In-Chief of Investigative Ophthalmology and Visual Science and as a member of the National Advisory Eye Council. After 32 years of service as Chair, Dr. Laties continues to serve as a Vice Chair of the Scientific Advisory Board of the Foundation Fighting Blindness. Currently he is the Harold G. Scheie-Nina C. Mackall Research Professor of Ophthalmology at the University of Pennsylvania Medical School.
Jonathan S. Myers, MD, is an Associate Attending Surgeon on the Glaucoma Service of Wills Eye Hospital. Dr. Myers received his bachelor’s in chemistry at Princeton University magna cum laude and his medical degree from the University of Pennsylvania. He was selected as Chief Resident during his residency at Wills Eye Hospital, then completed a fellowship in glaucoma at Duke University. Dr. Myers now serves as Director of the Glaucoma Fellowship at Wills Eye Hospital in Philadelphia, Pennsylvania.
Dr. Myers has authored and co-authored numerous articles in peer reviewed journals and has lectured internationally regarding the diagnosis and treatment of glaucoma. He serves on the editorial boards of Glaucoma Today and the Journal of Clinical and Experimental Ophthalmology. Current research interests include perimetry and novel glaucoma surgeries. He has been recognized by his peers as a Philadelphia Magazine Top Doc, 2010-2013, and in America’s Top Doctors, 9th-12th editions. He is in clinical practice at Wills Eye Institute.
Robert J. Noecker, MD, MBA, is currently in private practice in Fairfield, CT with Ophthalmic Consultants of Connecticut. He is also is an Assistant Clinical Professor at the Yale University School of Medicine. He has published on, teaches and performs novel glaucoma surgical techniques. He specializes in complex pediatric and adult glaucoma cases especially in combination with cataract surgery. He also specializes in complicated lens implant repositioning and replacement techniques.
Dr. Noecker has over 18 years of experience in developing innovations in imaging, and medical, laser and surgical therapies for glaucoma; Dr. Noecker has conducted over 50 trials on the pharmacologic and surgical treatment of glaucoma, macular degeneration and dry eyes. Dr. Noecker has also helped to innovate and apply novel new materials and surgical techniques to the treatment of glaucoma. He is on the editorial board of many peer-reviewed journals in ophthalmology, has published over 100 peer-reviewed papers and has lectured around the world on 6 continents and over 25 countries.
Prior to joining OCC, Dr. Noecker was the Vice Chair of UPMC Eye Center, Director of the Glaucoma Service, and Professor of Ophthalmology at the University of Pittsburgh School of Medicine. He was associate director of the electronic health record at UPMC, director of telemedicine for ophthalmology and director of glaucoma at the Pittsburgh VA hospital and the teleretina program for Ophthalmology. Prior to Pittsburgh, he was on the faculty at Tufts University and was Director of Glaucoma and the Ophthalmology residency program at the University of Arizona School of Medicine. Dr. Noecker did his undergraduate work at MIT, medical school at the University of North Carolina in Chapel Hill, residency in Ophthalmology at the University of Arizona and Fellowship in glaucoma at Tufts University in Boston. He received his M.B.A. from the Eller School of Management at the University of Arizona.
Leonard A. Levin, MD, PhD, is Chair of the Department of Ophthalmology, McGill University, Physician-in-Chief of Ophthalmology at the McGill University Health Centre (MUHC), Adjunct Professor of Ophthalmology at the Université de Montréal, and Professor of Ophthalmology at the University of Wisconsin. He did his undergraduate, graduate, and medical training at Harvard, and then pursued an ophthalmology residency and neuro-ophthalmology fellowship at the Massachusetts Eye and Ear Infirmary
His research program focuses on mechanisms of retinal ganglion cell death at the molecular, tissue culture, and whole animal level. This includes the role axonal damage plays in inducing loss of retinal ganglion cells and how axons themselves undergo injury, an area common to ophthalmology and neurology. He is particularly interested in using advanced imaging techniques to study signaling of cell death in the retina and the development of new drugs for optic nerve and retinal disease. This and related research has resulted in more than 160 peer-reviewed papers, reviews, and book chapters, 4 issued and 1 pending patents, and his editing of five textbooks in the visual sciences or ophthalmology, including Ocular Disease: Mechanisms and Management, and the recent 11th edition of Adler’s Physiology of the Eye. He is past chair of the Diseases and Pathophysiology of the Visual System study section at the United States National Institutes of Health and has been an ad hoc reviewer for the Canadian Institutes of Health Research, and funding bodies in Hong Kong, Israel, Australia, and elsewhere.
Dr. Levin is particularly interested in the challenges associated with successfully translating basic science research into clinically effective therapies, and has been involved with the design and assessment of clinical trials to study neuroprotective therapies in glaucoma and other optic neuropathies.
Dr. Amato attended Colgate University as an undergraduate and Cornell University for his graduate degree. He is also a former Assistant Professor for the Harvard School of Public Health Education.